Patient-reported health not associated with keratinocyte carcinoma treatment choice in a Medicare cohort of older adults.
Patient-reported health not associated with keratinocyte carcinoma treatment choice in a Medicare cohort of older adults.
Br J Dermatol. 2019 Sep 20;:
Authors: Wehner MR, Kwong PL, Kurichi JE, Xie D, Hennessy S, Margolis DJ
Abstract
Keratinocyte carcinomas (KCs; basal cell carcinoma [BCC] and squamous cell carcinoma [SCC]), are common in older adults, with 2.1 million yearly in United States (US) Medicare patients.1 Common treatments include destruction (typically electrodessication and curettage), surgical excision, and Mohs micrographic surgery (MMS), all of which can offer cure rates >90%2,3 (highest for MMS, followed by excision, then destruction).
PMID: 31539166 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - Category: Dermatology Authors: Wehner MR, Kwong PL, Kurichi JE, Xie D, Hennessy S, Margolis DJ Tags: Br J Dermatol Source Type: research
More News: Basal Cell Carcinoma | Cancer & Oncology | Carcinoma | Dermatology | Medicare | Skin | Skin Cancer | Squamous Cell Carcinoma | UK Health | USA Health